Acambis reports positive data for flu vaccine
UK group Acambis has kicked off the year with a good start, announcing encouraging results from a Phase I clinical trial and a preclinical challenge study of its candidate flu vaccine.
Read MoreAuthor: Selina McKee
Devolution has split NHS, claims Confederation boss
NHS Confederation Chief Gill Morgan has claimed that devolution of Great Britain has given rise to a National Health Service that operates under four different systems.
Read More- Acoramidis approved for heart condition treatment
- Genomics study launches to optimise childhood cancer care in Ireland
- UCL researchers launch congenital muscular dystrophy research programme
- Novavax shares positive real-world results for JN.1-adapted COVID-19 vaccine
- FDA approves Click’s digital therapeutic for episodic migraine
